HEPATORENAL SYNDROME
Clinical trials for HEPATORENAL SYNDROME explained in plain language.
Never miss a new study
Get alerted when new HEPATORENAL SYNDROME trials appear
Sign up with your email to follow new studies for HEPATORENAL SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a lung drug save kidneys in liver patients?
Disease control OngoingThis study tests whether ambrisentan, a drug approved for lung blood pressure, can help patients with hepatorenal syndrome—a serious kidney problem that can occur in advanced liver cirrhosis. About 54 hospitalized adults will receive either ambrisentan or the standard drug terlip…
Matched conditions: HEPATORENAL SYNDROME
Phase: PHASE2 • Sponsor: Noorik Biopharmaceuticals AG • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New device hopes to help kidneys in liver patients
Disease control TerminatedThis study tests a device called the Selective Cytopheretic Device (SCD) in ICU patients with acute kidney injury and hepatorenal syndrome, a serious complication of liver disease. The device filters white blood cells from the blood for 7 days to see if it improves kidney functio…
Matched conditions: HEPATORENAL SYNDROME
Phase: NA • Sponsor: Lenar Yessayan • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC